Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery

NCT02249949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Liposarcoma

Interventions

DRUG: efatutazone

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]